Don Startt

Don Startt leads the upstream process development group for REGENXBIO. His team is responsible for the development, optimization, and scale-up of AAV gene therapy manufacturing processes. Prior to his current position, he has held roles at REGENXBIO, GSK and Human Genome Sciences in various CMC-related positions including Manufacturing Sciences, Project Management, Quality, Operations and Facility Design working on biotechnology-based processes and products at all lifecycle stages.

Pin It on Pinterest